Clinical Trial Update: Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on treating heart failure with human umbilical cord mesenchymal stem cells (hUC-MSC) across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Ischemia
• Ventricular Dysfunction

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Myocardial Ischemia, Ventricular Dysfunction, Left | Phase 1, Phase 2 | Status: UNKNOWN